Learn More
Selleck Chemical LLC BAW2881

Supplier: Selleck Chemical LLC S81895MG
BAW2881 (NVP-BAW2881) is a novel vascular endothelial growth factor (VEGF) receptor tyrosine-kinase inhibitor that potently inhibits VEGFR1-3 at 1 0-4 3 nanomolar (nM) concentrations and inhibits PDGFR c-Kit and RET (c-RET) at 45-72 nM concentrations
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.